Results 81 to 90 of about 271,261 (306)

Plasma levels of α1-antitrypsin-derived C-terminal peptides in PiMM and PiZZ COPD patients

ERJ Open Research, 2023
Friedemann R. Börner, Urszula Lechowicz, Sabine Wrenger, Beatriz Martinez-Delgado, Beata Olejnicka, Tobias Welte, Joanna Chorostowska-Wynimko, Michael Kiehntopf, Sabina Janciauskiene   +8 more
doaj   +1 more source

Age-related changes in the respiratory system [PDF]

, 1999
This article summarises the main structural and physiological changes which take place in the lung from young adulthood to senescence. An understanding of these changes helps the clinician to correctly interpret some results of radiology and pulmonary ...
Ebejer, Martin J., Lesauskaite, Vita
core  

European Respiratory Society International Congress best abstract preview from the allied respiratory professionals from assembly 9 [PDF]

, 2018
The 28th European Respiratory Society (ERS) International Congress [2018] in Paris features interesting research findings within the allied respiratory professional assembly (assembly 9).
Blonshine, Jason, Cruz, Joana, De Brandt, Jana, Sajnic, Andreja   +3 more
core   +1 more source

Proportion of Acceptable Symptom State Nearly Tripled With Improvements in Patient‐Reported Outcomes for All Symptom State Subgroups: A Registry Study of More Than 15,000 Patients With Osteoarthritis in Digital Education and Exercise Therapy

Arthritis Care &Research, EarlyView.
Objective This study investigated trajectories of patient acceptable symptom state (PASS) among participants of digital education and exercise therapy for knee and hip osteoarthritis. Methods A longitudinal observational study among individuals aged at least 40 years who participated in the digital program.
Ali Kiadaliri, L. Stefan Lohmander, Amanda E. Nelson, Leif E. Dahlberg   +3 more
wiley   +1 more source

Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections

Nature Communications, 2018
Pulmonary infections constitute a substantial health problem worldwide. Here the authors show that phagocytes similar to primitive macrophages can be generated from human induced pluripotent stem cells, by the use of industry-compatible, stirred-tank ...
Mania Ackermann, Henning Kempf, Miriam Hetzel, Christina Hesse, Anna Rafiei Hashtchin, Kerstin Brinkert, Juliane Wilhelmine Schott, Kathrin Haake, Mark Philipp Kühnel, Silke Glage, Constanca Figueiredo, Danny Jonigk, Katherina Sewald, Axel Schambach, Sabine Wronski, Thomas Moritz, Ulrich Martin, Robert Zweigerdt, Antje Munder, Nico Lachmann   +19 more
doaj   +1 more source

Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care : a real-world study [PDF]

, 2016
Acknowledgements Samantha Holmes (CircleScience, an Ashfield Company, part of UDG Healthcare plc) and Paul Hutchin (contracted to CircleScience, an Ashfield Company, part of UDG Healthcare plc) provided medical writing assistance.
Baldwin, Michael, Brusselle, Guy, Davis, Emily, Gruffydd-Jones, Kevin, Jones, Rupert, Keininger, Dorothy L., Miravitlles, Marc, Price, David, Rigazio, Anna, Stewart, Rebecca   +9 more
core   +3 more sources

Heterogeneity of Rheumatoid Arthritis–Associated Interstitial Lung Disease by Longitudinal Forced Vital Capacity Trajectory and Associations With Disease Outcomes

Arthritis Care &Research, EarlyView.
Objective We aimed to identify unique disease trajectories within rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) based on longitudinal forced vital capacity (FVC) values and their associated clinical outcomes. Methods We performed a cohort study of RA‐ILD within the Veterans Health Administration from 1999 to 2021.
Bryant R. England, Yangyuna Yang, Punyasha Roul, Tate M. Johnson, Scott M. Matson, Grant W. Cannon, Brian C. Sauer, Jeffrey R. Curtis, Joshua F. Baker, Ted R. Mikuls   +9 more
wiley   +1 more source

Design of the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) AIR Study. [PDF]

, 2017
IntroductionPopulation-based epidemiological evidence suggests that exposure to ambient air pollutants increases hospitalisations and mortality from chronic obstructive pulmonary disease (COPD), but less is known about the impact of exposure to air ...
Alexis, Neil, Barr, R Graham, Bleecker, Eugene, Bowler, Russell, Breysse, Patrick J, Comellas, Alejandro P, Cooper, Christopher B, Dransfield, Mark, Fan, Vincent S, Gassett, Amanda J, Han, MeiLan K, Hansel, Nadia N, Kaufman, Joel D, Kim, Victor, Krishnan, Jerry A, Martinez, Fernando, Paulin, Laura M, Peng, Roger D, Pirozzi, Cheryl, Woodruff, Prescott G   +19 more
core   +2 more sources

Obstructive lung diseases

, 2023
Obstructive lung disease is a category of lung disease characterized by difficulty exhaling air from the lungs due to airway obstruction. Obstruction can be caused by many factors, including inflammation, mucus accumulation, bronchial constriction, or damage to lung tissue.
Menekli, Tugba, Yilmaz, Feride T., Demirci, Pinar Y   +2 more
openaire   +1 more source

Rethinking Strategies for a Pharmaceutical Approach to Pain Related to Connective Tissue–Related Raynaud Phenomenon in the United States

Arthritis Care &Research, EarlyView.
Objective There are no US Food and Drug Administration–approved therapies for Raynaud phenomenon (RP) in the United States. Clinical trials have been challenged by study design. Important advances in RP patient‐reported outcome measures and mechanistic quantification allow RP‐related pain characterization.
Tracy M. Frech, Charles G. Frech, W. David Merryman, Andrew Sternlicht, Justin Baba   +4 more
wiley   +1 more source